Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Julie M. Lisano"'
Autor:
Alejandro A. Gru, Megan S. Lim, Ahmet Dogan, Steven M. Horwitz, Jan Delabie, Kai Fu, Deniz Peker, Vishnu V. B. Reddy, Mina L. Xu, Kiran Vij, Graham W. Slack, Roberto N. Miranda, Deepa Jagadeesh, Julie M. Lisano, Eric D. Hsi, Emina Torlakovic
Publikováno v:
Archives of Pathology & Laboratory Medicine. 147:79-86
Context.—Although CD30 testing is an established tool in the diagnostic workup of lymphomas, it is also emerging as a predictive biomarker that informs treatment. The current definition of CD30 positivity by immunohistochemistry is descriptive and
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d48f66234f88b77fc896c0e28c34f6d4
https://doi.org/10.5858/arpa.2021-0270-oa
https://doi.org/10.5858/arpa.2021-0270-oa
Autor:
Armando Santoro, Alison J Moskowitz, Silvia Ferrari, Carmelo Carlo-Stella, Julie M Lisano, Stephen Francis, Rachael Wen, Alev Akyol, Kerry J. Savage
Publikováno v:
Blood.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::faed564abb7e36ddcf846e502b28929c
https://doi.org/10.1182/blood.2022017951
https://doi.org/10.1182/blood.2022017951
Autor:
Paul Harker-Murray, Christine Mauz-Körholz, Thierry M Leblanc, Maurizio Mascarin, Gérard Michel, Stacy Cooper, Auke Beishuizen, Kasey J. Leger, Loredana Amoroso, Salvatore Buffardi, Charlotte Rigaud, Bradford S. Hoppe, Julie M Lisano, Stephen Francis, Mariana Sacchi, Peter D. Cole, Richard A. Drachtman, Kara M. Kelly, Stephen Daw
Publikováno v:
Blood.
Children, adolescents, and young adults (CAYA) with relapsed/refractory classical Hodgkin lymphoma (cHL) without complete metabolic response (CMR) before autologous hematopoietic cell transplantation (auto-HCT) have poor survival outcomes. CheckMate
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::aab1911678be950a0b7e4cb188907ed6
https://doi.org/10.1182/blood.2022017118
https://doi.org/10.1182/blood.2022017118
Autor:
Julie M. Lisano, Joel W. Neal, Manuel Modiano, Robert M. Jotte, Alex A. Adjei, Natasha B. Leighl, Heather A. Wakelee, Liming Liu, Julie R. Brahmer, Hongbin Chen, James R. Rigas
Publikováno v:
Journal of Clinical Oncology. 30:7541-7541
7541 Background: AFL is a recombinant human fusion protein that acts as a decoy receptor and prevents the interaction of vascular endothelial growth factor (VEGF)-A, VEGF-B, and placental growth factor with their receptors. This study evaluated the e
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::cc18ea7e66b37e5248d3f7c4b4043c08
https://doi.org/10.1200/jco.2012.30.15_suppl.7541
https://doi.org/10.1200/jco.2012.30.15_suppl.7541